John M. Kane, MD
The Zucker Hillside Hospital, Northwell Health, Department of Psychiatry, Glen Oaks, New York; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, New York; Corresponding author: John M. Kane, MD, Senior Vice President, Behavioral Health Services, Zucker Hillside Hospital, Northwell Health, 75-59 263rd St, Glen Oaks, NY 11004 ([email protected]).
Original Research
Valbenazine for Tardive Dyskinesia: Results From the KINECT 3 Study
December 18, 2018
Could valbenazine help your patients who experience antipsychotic-induced abnormal movements? This follow-up analysis of a phase 3 study provides further insights into the efficacy of valbenazine for tardive dyskinesia...